Effect of an exercise bout before the booster dose of an inactivated SARS-CoV-2 vaccine on immunogenicity in immunocompromised patients-Reference-Cited by-同舟云学术

Effect of an exercise bout before the booster dose of an inactivated SARS-CoV-2 vaccine on immunogenicity in immunocompromised patients

Published:2022-03-01 Issue:3 Volume:132 Page:682-688
ISSN:8750-7587
Container-title:Journal of Applied Physiology
language:en
Short-container-title:Journal of Applied Physiology

Author:

Gualano Bruno¹²^ORCID,Saad Carla G. S.³,Sieczkowska Sofia M.¹^ORCID,Lemes Ítalo Ribeiro¹,da Silva Rafael Pires¹,Pinto Ana J.¹⁴^ORCID,Mazzolani Bruna C.¹,Smaira Fabiana I.¹^ORCID,Gil Saulo¹,Oliveira-Junior Gersiel¹,Aikawa Nadia E.³,Medeiros-Ribeiro Ana C.³,Silva Clovis A.³⁵,Yuki Emily F. N.³^ORCID,Pasoto Sandra G.³,Pereira Rosa Maria R.³,Shinjo Samuel K.³,Andrade Danieli C. O.³,Sampaio-Barros Percival D.³,Roschel Hamilton¹^ORCID,Bonfa Eloisa³

Affiliation:

1. Applied Physiology & Nutrition Research Group, Division of Rheumatology, Faculdade de Medicina FMUSP, School of Physical Education and Sport, Universidade de Sao Paulo, Sao Paulo, Brazil

2. Food Research Center, University of São Paulo, Sao Paulo, Brazil

3. Division of Rheumatology, Faculdade de Medicina, Hospital das Clínicas HCFMUSP, Universidade de Sao Paulo, Sao Paulo, Brazil

4. Division of Endocrinology, Metabolism, and Diabetes and Anschutz Health and Wellness Center, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado

5. Pediatric Rheumatology Unit, Faculdade de Medicina, Instituto da Criança e do Adolescente, Hospital das Clínicas HCFMUSP, Universidade de Sao Paulo, Sao Paulo, Brazil

Abstract

We tested the role of exercise as an adjuvant to a booster of a COVID-19 vaccine. Immunocompromised patients were immunized after an acute bout of exercise or not. Patients exhibited an excellent immunogenicity in response to the booster dose. Exercise did not add to the vaccine effects on IgG or neutralizing antibodies.

Funder

Fundação de Amparo à Pesquisa do Estado de São Paulo

Publisher

American Physiological Society

Subject

Physiology (medical),Physiology

Link

https://journals.physiology.org/doi/pdf/10.1152/japplphysiol.00015.2022

Reference23 articles.

1. Immunogenicity and safety of two doses of the CoronaVac SARS-CoV-2 vaccine in SARS-CoV-2 seropositive and seronegative patients with autoimmune rheumatic diseases in Brazil: a subgroup analysis of a phase 4 prospective study

2. Immunogenicity and safety of anti-SARS-CoV-2 mRNA vaccines in patients with chronic inflammatory conditions and immunosuppressive therapy in a monocentric cohort

3. Immunogenicity and safety of the CoronaVac inactivated vaccine in patients with autoimmune rheumatic diseases: a phase 4 trial

4. Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in adult patients with autoimmune inflammatory rheumatic diseases and in the general population: a multicentre study

5. Case Study: Prolonged Infectious SARS-CoV-2 Shedding from an Asymptomatic Immunocompromised Individual with Cancer

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Coronavirus disease 2019 vaccination in patients with rheumatic diseases: A bibliometric‐based analysis of trends;Rheumatology & Autoimmunity;2024-06

2. Moderate exercise induces trained immunity in macrophages;American Journal of Physiology-Cell Physiology;2023-08-01

3. Physical Activity as a Protective Factor of COVID-19;Physical Activity and Pandemics;2023